December 17, 2025 - ATLANTA - On Tuesday, the Centers for Disease Control and Prevention released the following: The Centers for Disease Control and Prevention (CDC) today adopted individual-based decision-making for hepatitis B immunization for parents deciding whether to give the hepatitis B vaccine,

For decades, newborns in the U.S. have been given the hepatitis B vaccine. This could change. A CDC vaccine advisory panel may vote to end that routine vaccination. Here's what parents should know.

John Ellis had barely heard of hepatitis B when he was diagnosed with the potentially fatal disease at age 16.

A rapid, highly accurate test has been developed for diagnosing hepatitis C virus (HCV), according to a study published online Dec. 10 in the Journal of Infectious Diseases.

Vaccinating babies for hepatitis B at birth remains one of the clearest, most evidence-based ways to keep American children free of this lifelong, deadly infection. Despite that reality, the

Vir Biotechnology is handing off certain commercial rights for its hepatitis D program to European specialty pharma Norgine in a licensing deal that’s worth up to 550 million euros ($645 million) a | Norgine secured an exclusive license to commercialize Vir Biotechnology's combo hepatitis D prospect of tobevibart and elebsiran in Europe,